These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 24075476)

  • 1. Plasma treated with methylene blue and light: clinical efficacy and safety profile.
    Lozano M; Cid J; Müller TH
    Transfus Med Rev; 2013 Oct; 27(4):235-40. PubMed ID: 24075476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative evaluation of plasma after methylene blue and white light treatment in four Chinese blood centers.
    Chunhui Y; Guohui B; Hong Y; Xiaopu X; Zherong B; Mingyuan W; Xinsheng Z; Juanjuan W; Changqing L; Wuping L
    Transfus Apher Sci; 2013 Dec; 49(3):631-9. PubMed ID: 23928128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two pathogen reduction technologies--methylene blue plus light and shortwave ultraviolet light--effectively inactivate hepatitis C virus in blood products.
    Steinmann E; Gravemann U; Friesland M; Doerrbecker J; Müller TH; Pietschmann T; Seltsam A
    Transfusion; 2013 May; 53(5):1010-8. PubMed ID: 22905868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombin generation and clot formation in methylene blue-treated plasma and cryoprecipitate.
    Cardigan R; Philpot K; Cookson P; Luddington R
    Transfusion; 2009 Apr; 49(4):696-703. PubMed ID: 19170989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Storage of thawed plasma for a liquid plasma bank: impact of temperature and methylene blue pathogen inactivation.
    Thiele T; Kellner S; Hron G; Wasner C; Nauck M; Zimmermann K; Wessel A; Warkentin TE; Greinacher A; Selleng K
    Transfusion; 2012 Mar; 52(3):529-36. PubMed ID: 21880044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on pathogen reduction technology for therapeutic plasma: an overview.
    Solheim BG; Seghatchian J
    Transfus Apher Sci; 2006 Aug; 35(1):83-90. PubMed ID: 16934528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A biochemical comparison of a pharmaceutically licensed coagulation active plasma (Octaplas) with a universally applicable development product (Uniplas) and single-donor FFPs subjected to methylene-blue dye and white-light treatment.
    Heger A; Römisch J; Svae TE
    Transfus Apher Sci; 2006 Dec; 35(3):223-33. PubMed ID: 17118709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cryoprecipitate prepared from plasma treated with methylene blue plus light: increasing the fibrinogen concentration.
    Hornsey VS; Young DA; Docherty A; Hughes W; Prowse CV
    Transfus Med; 2004 Oct; 14(5):369-74. PubMed ID: 15500456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. International, prospective haemovigilance study on methylene blue-treated plasma.
    Noens L; Vilariño MD; Megalou A; Qureshi H
    Vox Sang; 2017 May; 112(4):352-359. PubMed ID: 28345172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on the use of pathogen-reduced human plasma and platelet concentrates.
    Seltsam A; Müller TH
    Br J Haematol; 2013 Aug; 162(4):442-54. PubMed ID: 23710899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dengue and chikungunya viruses in plasma are effectively inactivated after treatment with methylene blue and visible light.
    Fryk JJ; Marks DC; Hobson-Peters J; Prow NA; Watterson D; Hall RA; Young PR; Reichenberg S; Sumian C; Faddy HM
    Transfusion; 2016 Sep; 56(9):2278-85. PubMed ID: 27456861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coagulation function in fresh-frozen plasma prepared with two photochemical treatment methods: methylene blue and amotosalen.
    Osselaer JC; Debry C; Goffaux M; Pineau J; Calomme G; Dubuc E; Chatelain B; Vandendaele MC; Hsu J; Rheinschmidt M; Lin L
    Transfusion; 2008 Jan; 48(1):108-17. PubMed ID: 17900283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombin generation capacity is impaired in methylene-blue treated plasma compared to normal levels in single-donor fresh-frozen plasma, a licensed solvent/detergent-treated plasma (Octaplas) and a development product (Uniplas).
    Pock K; Heger A; Janisch S; Svae TE; Römisch J
    Transfus Apher Sci; 2007 Dec; 37(3):223-31. PubMed ID: 18006380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogen reduction of blood components.
    Solheim BG
    Transfus Apher Sci; 2008 Aug; 39(1):75-82. PubMed ID: 18602343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical use of virally inactived plasma. The experience of Blood Transfusion Unit in Mantova, Italy].
    Lepri D; Capuzzo E; Mattioli AV; Dall'Oglio D; Sgarioto V; Terenziani I; Caramaschi G; Manzato F; Franchini M
    Recenti Prog Med; 2013 Mar; 104(3):106-11. PubMed ID: 23548954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality and safety of fresh-frozen plasma inactivated and leucoreduced with the Theraflex methylene blue system including the Blueflex filter: 5 years' experience.
    Politis C; Kavallierou L; Hantziara S; Katsea P; Triantaphylou V; Richardson C; Tsoutsos D; Anagnostopoulos N; Gorgolidis G; Ziroyannis P
    Vox Sang; 2007 May; 92(4):319-26. PubMed ID: 17456156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of methylene blue/photochemical method for virus inactivation on plasma components].
    Zhou XP; Xu JB; Sun P; Yan F; Wang QL; Bu FR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Jun; 11(3):305-7. PubMed ID: 12844419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma temperature during methylene blue/light treatment influences virus inactivation capacity and product quality.
    Gravemann U; Handke W; Sumian C; Alvarez I; Reichenberg S; Müller TH; Seltsam A
    Vox Sang; 2018 May; 113(4):368-377. PubMed ID: 29484670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cryoprecipitate prepared from methylene blue-treated fresh plasma.
    Hornsey V; Young D; Prowse C
    Transfusion; 2001 Jan; 41(1):151-2. PubMed ID: 11161260
    [No Abstract]   [Full Text] [Related]  

  • 20. Quantitative analysis of plasma proteins in whole blood-derived fresh frozen plasma prepared with three pathogen reduction technologies.
    Larrea L; Ortiz-de-Salazar MI; Martínez P; Roig R
    Transfus Apher Sci; 2015 Jun; 52(3):305-10. PubMed ID: 25656475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.